China SXT Stock Forecast - Naive Prediction

SXTC Stock  USD 1.25  0.75  37.50%   
The Naive Prediction forecasted value of China SXT Pharmaceuticals on the next trading day is expected to be 1.35 with a mean absolute deviation of 0.07 and the sum of the absolute errors of 4.25. China Stock Forecast is based on your current time horizon. Investors can use this forecasting interface to forecast China SXT stock prices and determine the direction of China SXT Pharmaceuticals's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of China SXT's historical fundamentals, such as revenue growth or operating cash flow patterns.
At the present time, the relative strength index (RSI) of China SXT's share price is approaching 44. This usually implies that the stock is in nutural position, most likellhy at or near its support level. The main point of RSI analysis is to track how fast people are buying or selling China SXT, making its price go up or down.

Momentum 44

 Sell Extended

 
Oversold
 
Overbought
The successful prediction of China SXT's future price could yield a significant profit. We analyze noise-free headlines and recent hype associated with China SXT Pharmaceuticals, which may create opportunities for some arbitrage if properly timed. Below are the key fundamental drivers impacting China SXT's stock price prediction:
Quarterly Earnings Growth
0.426
Quarterly Revenue Growth
(0.24)
Using China SXT hype-based prediction, you can estimate the value of China SXT Pharmaceuticals from the perspective of China SXT response to recently generated media hype and the effects of current headlines on its competitors.
The Naive Prediction forecasted value of China SXT Pharmaceuticals on the next trading day is expected to be 1.35 with a mean absolute deviation of 0.07 and the sum of the absolute errors of 4.25.

China SXT after-hype prediction price

    
  USD 1.25  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of China SXT to cross-verify your projections.
At present, China SXT's Payables Turnover is projected to increase slightly based on the last few years of reporting. The current year's Receivables Turnover is expected to grow to 1.21, whereas Fixed Asset Turnover is forecasted to decline to 4.86. . The current year's Common Stock Shares Outstanding is expected to grow to about 487.7 K, whereas Net Loss is projected to grow to (4.9 M).

China SXT Additional Predictive Modules

Most predictive techniques to examine China price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for China using various technical indicators. When you analyze China charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

China SXT Cash Forecast

Forecasting cash, or other financial indicators, requires analysts to apply different statistical methods, techniques, and algorithms to find hidden patterns within the China SXT's financial statements to predict how it will affect future prices.
 
Cash  
First Reported
2016-03-31
Previous Quarter
18.1 M
Current Value
21.2 M
Quarterly Volatility
6.9 M
 
Yuan Drop
 
Covid
A naive forecasting model for China SXT is a special case of the moving average forecasting where the number of periods used for smoothing is one. Therefore, the forecast of China SXT Pharmaceuticals value for a given trading day is simply the observed value for the previous period. Due to the simplistic nature of the naive forecasting model, it can only be used to forecast up to one period.

China SXT Naive Prediction Price Forecast For the 10th of January

Given 90 days horizon, the Naive Prediction forecasted value of China SXT Pharmaceuticals on the next trading day is expected to be 1.35 with a mean absolute deviation of 0.07, mean absolute percentage error of 0.01, and the sum of the absolute errors of 4.25.
Please note that although there have been many attempts to predict China Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that China SXT's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).

China SXT Stock Forecast Pattern

Backtest China SXTChina SXT Price PredictionBuy or Sell Advice 

China SXT Forecasted Value

In the context of forecasting China SXT's Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. China SXT's downside and upside margins for the forecasting period are 0.01 and 9.21, respectively. We have considered China SXT's daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Market Value
1.25
1.35
Expected Value
9.21
Upside

Model Predictive Factors

The below table displays some essential indicators generated by the model showing the Naive Prediction forecasting method's relative quality and the estimations of the prediction error of China SXT stock data series using in forecasting. Note that when a statistical model is used to represent China SXT stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.
AICAkaike Information Criteria115.4092
BiasArithmetic mean of the errors None
MADMean absolute deviation0.0685
MAPEMean absolute percentage error0.046
SAESum of the absolute errors4.2462
This model is not at all useful as a medium-long range forecasting tool of China SXT Pharmaceuticals. This model is simplistic and is included partly for completeness and partly because of its simplicity. It is unlikely that you'll want to use this model directly to predict China SXT. Instead, consider using either the moving average model or the more general weighted moving average model with a higher (i.e., greater than 1) number of periods, and possibly a different set of weights.

Predictive Modules for China SXT

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as China SXT Pharmaceuticals. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of China SXT's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
0.061.259.04
Details
Intrinsic
Valuation
LowRealHigh
0.061.219.00
Details

Other Forecasting Options for China SXT

For every potential investor in China, whether a beginner or expert, China SXT's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. China Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in China. Basic forecasting techniques help filter out the noise by identifying China SXT's price trends.

China SXT Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with China SXT stock to make a market-neutral strategy. Peer analysis of China SXT could also be used in its relative valuation, which is a method of valuing China SXT by comparing valuation metrics with similar companies.
 Risk & Return  Correlation

China SXT Pharmaceuticals Technical and Predictive Analytics

The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of China SXT's price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of China SXT's current price.

China SXT Market Strength Events

Market strength indicators help investors to evaluate how China SXT stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading China SXT shares will generate the highest return on investment. By undertsting and applying China SXT stock market strength indicators, traders can identify China SXT Pharmaceuticals entry and exit signals to maximize returns.

China SXT Risk Indicators

The analysis of China SXT's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in China SXT's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting china stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether China SXT Pharmaceuticals offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of China SXT's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of China Sxt Pharmaceuticals Stock. Outlined below are crucial reports that will aid in making a well-informed decision on China Sxt Pharmaceuticals Stock:
Check out Historical Fundamental Analysis of China SXT to cross-verify your projections.
You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.
Is Personal Care Products space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of China SXT. If investors know China will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about China SXT listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.426
Earnings Share
(0.38)
Revenue Per Share
0.027
Quarterly Revenue Growth
(0.24)
Return On Assets
(0.18)
The market value of China SXT Pharmaceuticals is measured differently than its book value, which is the value of China that is recorded on the company's balance sheet. Investors also form their own opinion of China SXT's value that differs from its market value or its book value, called intrinsic value, which is China SXT's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because China SXT's market value can be influenced by many factors that don't directly affect China SXT's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between China SXT's value and its price as these two are different measures arrived at by different means. Investors typically determine if China SXT is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, China SXT's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.